Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

INSERM claims antitumor antibody

Oct. 25, 1996

SRI and Taiho to develop new approach to breast cancer

Oct. 25, 1996

NIH seeks licensees for dual topoisomerase/tubulin polymerization inhibitor

Oct. 25, 1996

Enzon selects Medac as marketing partner for Oncaspar

Oct. 25, 1996

Isis antisense compound and analogues covered by U.S. patent

Oct. 18, 1996

Targeted Genetics receives grant for its HER-2/neu oncogene inhibitor

Oct. 18, 1996

Natural antitumor indanone reported by Sagami

Oct. 18, 1996

Eisai claims RXR agonists

Oct. 18, 1996

New antitumor agents from Sagami

Oct. 18, 1996

VCAM-1 inhibitors from Sagami

Oct. 18, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...